Sun Pharmaceutical Industries Limited — Important, 17-07-2025: General Updates

Sun Pharmaceutical Industries has established a new, wholly-owned subsidiary, Sun Pharma (Hainan) Company Limited, in China. This strategic move is designed to localize the production of its pharmaceutical products through prospective local partners for sales within China. This development signals the company's clear intent to deepen its footprint and expand market access in the growing Chinese pharmaceutical market, enhancing its global operational reach. Initial capital will be invested in cash.